Persistent Estrus and Hyperestrogenism

Persistent estrus and hyperestrogenism is a clinical syndrome in female dogs and cats characterized by prolonged or continuous signs of estrus (proestrus/estrus) lasting beyond the normal duration (typically >21 days in the bitch, >7-10 days in the queen), accompanied by elevated circulating estrogen concentrations. This condition results from excessive and sustained estrogen production, often due to ovarian follicular cysts, estrogen-secreting ovarian neoplasms (e.g., granulosa cell tumors), or iatrogenic administration of exogenous estrogens. Hyperestrogenism can lead to bone marrow suppression (pancytopenia), cystic endometrial hyperplasia, pyometra, and increased risk of mammary neoplasia. In the bitch, normal estrus lasts 5-9 days (range 3-21), with ovulation occurring 24-48 hours after the LH surge. Persistent estrus is defined as estrus exceeding 21 days. In the queen, estrus typically lasts 4-7 days, and persistent estrus is defined as >7-10 days. The syndrome is a significant reproductive disorder that requires prompt diagnosis and management to prevent life-threatening complications.

The primary etiologies of persistent estrus and hyperestrogenism include: 1) Functional ovarian follicular cysts: These are anovulatory follicles that persist and continue to produce estrogen. They may be single or multiple and can occur in any breed but are more common in older bitches. 2) Ovarian neoplasms: Granulosa cell tumors are the most common estrogen-secreting ovarian tumor in dogs and cats. Other tumors such as theca cell tumors, luteomas, and adenocarcinomas can also produce estrogen. 3) Iatrogenic hyperestrogenism: Administration of exogenous estrogens (e.g., estradiol cypionate for mismating) can cause prolonged estrus and bone marrow suppression. 4) Hepatic dysfunction: Impaired estrogen metabolism can lead to elevated circulating estrogen levels. 5) Rarely, adrenal tumors or ectopic estrogen production. In cats, persistent estrus is often due to ovarian remnants after ovariohysterectomy (ovarian remnant syndrome) or follicular cysts. The underlying mechanism involves excessive estrogen stimulation of target tissues, including the endometrium, bone marrow, and mammary glands.

Persistent estrus and hyperestrogenism can occur in any breed of dog or cat, but certain breeds may be predisposed to ovarian tumors, such as Boxers, German Shepherds, and Bulldogs for granulosa cell tumors. The condition is more common in middle-aged to older intact females (typically >6 years), but can occur in young animals due to follicular cysts. In dogs, the incidence of ovarian tumors is low (0.5-1.2% of all tumors), but granulosa cell tumors are the most common. In cats, ovarian tumors are rare, but granulosa cell tumors are also the most frequent. Iatrogenic hyperestrogenism is more common in dogs due to the use of estrogen-based mismating injections. There is no significant breed predisposition for follicular cysts, but they may be more common in nulliparous bitches. The condition is more likely in animals with irregular estrous cycles or those that have been bred unsuccessfully. In breeding kennels, improper estrus detection and breeding management can lead to prolonged estrus and misdiagnosis.

The pathophysiology of persistent estrus and hyperestrogenism involves sustained estrogen secretion from ovarian structures. In follicular cysts, the failure of ovulation leads to continued growth and estrogen production. Estrogen stimulates the endometrium, causing proliferation and hyperplasia. Chronic estrogen exposure leads to cystic endometrial hyperplasia (CEH), which predisposes to pyometra when progesterone is present. Estrogen also has a direct toxic effect on the bone marrow, causing initial leukocytosis followed by leukopenia, thrombocytopenia, and anemia (pancytopenia) due to suppression of hematopoietic stem cells. This is particularly severe with exogenous estrogen overdose. In ovarian tumors, estrogen secretion may be continuous and unopposed, leading to similar effects. Hyperestrogenism also causes squamous metaplasia of the vaginal epithelium, which is evident on cytology. In the queen, persistent estrus can lead to prolonged mating behavior and risk of pyometra. The exact mechanism of bone marrow suppression involves estrogen-induced apoptosis of hematopoietic progenitors and stromal cells. The severity of bone marrow suppression is dose-dependent and can be fatal.

Intrinsic factors include: age (middle-aged to older), breed (certain breeds for ovarian tumors), nulliparity, and genetic predisposition to ovarian cysts or tumors. Endocrine imbalances, such as hypothyroidism or hyperadrenocorticism, may predispose to ovarian dysfunction. Extrinsic factors include: iatrogenic administration of estrogens (e.g., mismating injections), improper use of progestins, and environmental stressors that disrupt normal cyclicity. Poor breeding management, such as breeding too early or too late, can lead to prolonged estrus. In cats, ovarian remnant syndrome after ovariohysterectomy is a predisposing factor for persistent estrus. Additionally, exposure to environmental estrogens (xenoestrogens) may contribute to hyperestrogenism, though this is less documented in veterinary medicine.

Clinical signs of persistent estrus and hyperestrogenism include: 1) Prolonged vulvar swelling and serosanguineous to sanguineous vaginal discharge lasting >21 days in dogs and >7-10 days in cats. 2) Attractiveness to males and standing heat behavior. 3) Increased urination, restlessness, and nervousness. 4) In severe hyperestrogenism, signs of bone marrow suppression: lethargy, pale mucous membranes, petechiae, ecchymoses, and fever due to secondary infections. 5) Polyuria and polydipsia if pyometra develops. 6) Abdominal distension if ovarian mass is large. 7) In cats, persistent calling (vocalization), rolling, and lordosis. 8) Mammary gland enlargement and possible galactorrhea. 9) In cases of ovarian neoplasia, palpable abdominal mass may be detected. 10) In advanced cases, signs of sepsis or hemorrhage due to thrombocytopenia.

Differential diagnoses include: 1) Normal proestrus/estrus: Differentiated by duration (<21 days) and normal progression to diestrus. 2) Split heat: A condition where estrus begins, then stops, and resumes later; often due to follicular atresia and new follicular waves. 3) Ovarian remnant syndrome: In spayed animals, residual ovarian tissue causes estrus signs; diagnosed by hormone assays and ultrasonography. 4) Vaginitis: Inflammation of the vagina can cause discharge and attraction of males, but cytology shows inflammatory cells and no cornified epithelial cells. 5) Urinary tract infection: Can cause vulvar discharge and increased urination, but no estrous behavior. 6) Pyometra: Often occurs after estrus, with purulent discharge and systemic signs; ultrasonography shows fluid-filled uterus. 7) Foreign body or trauma: Can cause vaginal discharge. 8) Neoplasia of the reproductive tract (e.g., vaginal tumors): Can cause discharge and swelling. 9) Hyperadrenocorticism: Can cause vulvar swelling and hormonal imbalances. 10) Exogenous estrogen administration: History of mismating injection. Definitive diagnosis relies on vaginal cytology, hormone assays (estrogen, progesterone), and imaging.

The diagnostic approach should be systematic: 1) Obtain a thorough history, including estrus cycle timing, breeding management, and any drug administration. 2) Perform a complete physical examination, including vulvar inspection, vaginal palpation, and abdominal palpation. 3) Collect vaginal cytology: Persistent estrus shows >80% superficial and cornified epithelial cells, with no neutrophils. 4) Measure serum progesterone: In persistent estrus, progesterone is typically <1 ng/mL (indicating no ovulation). If progesterone is >2 ng/mL, ovulation has occurred, and the diagnosis is not persistent estrus. 5) Measure serum estradiol: Elevated estradiol (>20 pg/mL in dogs) supports hyperestrogenism. 6) Perform abdominal ultrasonography: Look for ovarian follicles >1 cm in diameter (cysts), ovarian masses, and uterine changes (CEH, pyometra). 7) If ovarian remnant is suspected, perform an hCG stimulation test (25 IU/kg IV) and measure progesterone after 7 days. 8) Complete blood count to assess bone marrow suppression. 9) If pyometra is suspected, perform radiography or ultrasonography. 10) In cases of suspected neoplasia, consider fine-needle aspiration or biopsy. 11) Rule out other causes of prolonged estrus, such as thyroid or adrenal disease.

Hematology: In early hyperestrogenism, there may be mild leukocytosis. With chronic estrogen exposure, leukopenia, thrombocytopenia, and non-regenerative anemia develop. Severe cases show pancytopenia. Biochemistry: Liver enzymes may be elevated due to estrogen metabolism. In pyometra, azotemia, hyperglobulinemia, and hypoalbuminemia may be present. Serum progesterone: <1 ng/mL in persistent estrus (no ovulation). Serum estradiol: Elevated (>20 pg/mL in dogs, >15 pg/mL in cats). LH: May be suppressed due to negative feedback. Vaginal cytology: >80% superficial and cornified epithelial cells, no neutrophils, no bacteria. Urinalysis: May show hematuria or pyuria if pyometra is present. Uterine culture: If pyometra, culture yields E. coli, Streptococcus, or Staphylococcus. Bone marrow aspirate: Hypocellularity with reduced myeloid and erythroid precursors.

Abdominal ultrasonography: Ovaries may show multiple anechoic follicles >1 cm in diameter (follicular cysts). Ovarian masses may be complex or solid. Uterus may show thickened endometrium (CEH) or fluid-filled lumen (pyometra). In pyometra, uterine wall thickness >1 cm and intraluminal fluid with echogenic debris. Radiography: May show a soft tissue mass in the ovarian area or uterine enlargement. Fetal mineralization is not relevant unless pregnant. CT/MRI: Useful for staging ovarian neoplasia. Vaginoscopy: Shows hyperemic, edematous vaginal mucosa with a characteristic cobblestone appearance.

Vaginal cytology: Persistent estrus shows >80% superficial and cornified epithelial cells, with no neutrophils. Fine-needle aspirate of ovarian mass: May show granulosa cells, theca cells, or neoplastic cells. Histopathology of ovarian tissue: Follicular cysts are lined by granulosa cells and contain clear fluid. Granulosa cell tumors show characteristic Call-Exner bodies and may be benign or malignant. Endometrial biopsy: Shows cystic endometrial hyperplasia with dilated glands and stromal fibrosis. Bone marrow biopsy: Hypocellular with fatty infiltration.

Treatment depends on the underlying cause and severity. 1) For follicular cysts: Medical management with GnRH (e.g., deslorelin implant) or hCG (500 IU IM) to induce ovulation or luteinization. Alternatively, surgical removal of cysts via ovariectomy or ovariohysterectomy. 2) For ovarian neoplasia: Surgical excision (ovariohysterectomy) is the treatment of choice. 3) For iatrogenic hyperestrogenism: Discontinue exogenous estrogens. Supportive care for bone marrow suppression: blood transfusions, antibiotics, and colony-stimulating factors (e.g., filgrastim 5 mcg/kg SC q24h). 4) For pyometra: Emergency ovariohysterectomy or medical management with aglepristone (10 mg/kg SC on days 0, 1, 2, 8, 15) and prostaglandin F2alpha (dinoprost 0.1-0.25 mg/kg SC q8h) with careful monitoring. 5) For ovarian remnant syndrome: Surgical removal of remnant tissue. 6) Supportive care: Fluid therapy, nutritional support, and management of secondary infections. 7) In breeding animals, if the cause is follicular cysts, consider ovulation induction and timed breeding.

Prognosis is good for follicular cysts if treated early, with return to normal cyclicity. For ovarian neoplasia, prognosis depends on malignancy and metastasis; benign tumors have a good prognosis after surgical removal. For iatrogenic hyperestrogenism, prognosis is guarded to poor if severe bone marrow suppression occurs; mortality can be high. For pyometra, prognosis is good with early surgical intervention. Future fertility may be compromised if ovariohysterectomy is performed. Recurrence is possible if the underlying cause is not resolved.

After treatment, monitor estrous cycles. For medical management, recheck serum progesterone and estradiol levels weekly until normal. For surgical cases, monitor for complications. For bone marrow suppression, repeat CBC weekly until recovery. For pyometra, monitor for recurrence. For breeding animals, perform vaginal cytology and progesterone assays to time breeding. Annual reproductive health checks are recommended.

Pearls: 1) Always measure serum progesterone to confirm ovulation; persistent estrus is characterized by low progesterone (<1 ng/mL). 2) Vaginal cytology is essential for staging estrus. 3) Ultrasonography is crucial for detecting ovarian cysts or tumors. 4) In cases of hyperestrogenism, check a CBC for bone marrow suppression. 5) For ovarian remnant syndrome, use hCG stimulation test. Pitfalls: 1) Misdiagnosing persistent estrus as normal estrus, leading to inappropriate breeding. 2) Overlooking iatrogenic hyperestrogenism from mismating injections. 3) Delaying treatment for pyometra, which can be fatal. 4) Using estrogen therapy without monitoring for bone marrow toxicity. 5) Failing to consider ovarian neoplasia in older animals with persistent estrus.

1) GnRH (deslorelin) implant: 4.7 mg SC, lasts 6-12 months, used to suppress estrus or treat follicular cysts. 2) hCG: 500 IU IM for dogs, 250 IU IM for cats, to induce ovulation. 3) Aglepristone: 10 mg/kg SC on days 0, 1, 2, 8, 15 for pyometra or to terminate pregnancy. 4) Dinoprost (PGF2alpha): 0.1-0.25 mg/kg SC q8h for pyometra, with monitoring for side effects. 5) Cloprostenol: 1-2 mcg/kg SC q48h for pyometra. 6) Cabergoline: 5 mcg/kg PO q24h for 5-7 days to induce luteolysis. 7) Oxytocin: 1-5 IU/kg IM for uterine evacuation, but use with caution. 8) Calcium gluconate: 10% solution, 0.5-1.5 mL/kg IV slowly for eclampsia. 9) Antibiotics: Amoxicillin-clavulanate 12.5-25 mg/kg PO q8h or cephalexin 22 mg/kg PO q8h for pyometra. 10) Filgrastim: 5 mcg/kg SC q24h for neutropenia.

Studies have shown that follicular cysts are a common cause of persistent estrus in bitches, and treatment with GnRH or hCG is effective in inducing ovulation. Granulosa cell tumors are the most common ovarian neoplasia in dogs and cats, and ovariohysterectomy is curative if no metastasis. Iatrogenic hyperestrogenism from mismating injections is a well-documented cause of bone marrow suppression, with a poor prognosis if severe. The use of aglepristone and prostaglandins for pyometra has been validated in multiple studies, with success rates of 80-90% in open-cervix pyometra. Consensus guidelines from the American College of Theriogenologists and the European Society for Small Animal Reproduction recommend early diagnosis and treatment to preserve fertility and prevent complications.